Growth Metrics

Tenax Therapeutics (TENX) Return on Assets (2016 - 2017)

Historic Return on Assets for Tenax Therapeutics (TENX) over the last 5 years, with Q3 2017 value amounting to 2.8%.

  • Tenax Therapeutics' Return on Assets fell 24600.0% to 2.8% in Q3 2017 from the same period last year, while for Sep 2017 it was 2.8%, marking a year-over-year decrease of 24600.0%. This contributed to the annual value of 2.57% for FY2013, which is 18500.0% up from last year.
  • Tenax Therapeutics' Return on Assets amounted to 2.8% in Q3 2017, which was down 24600.0% from 2.38% recorded in Q2 2017.
  • Over the past 5 years, Tenax Therapeutics' Return on Assets peaked at 30.69% during Q1 2013, and registered a low of 40.36% during Q2 2013.
  • Over the past 3 years, Tenax Therapeutics' median Return on Assets value was 2.04% (recorded in 2017), while the average stood at 2.61%.
  • Examining YoY changes over the last 5 years, Tenax Therapeutics' Return on Assets showed a top increase of 326300bps in 2013 and a maximum decrease of -594200bps in 2013.
  • Quarter analysis of 3 years shows Tenax Therapeutics' Return on Assets stood at 40.36% in 2013, then soared by 97bps to 1.05% in 2016, then crashed by -168bps to 2.8% in 2017.
  • Its Return on Assets stands at 2.8% for Q3 2017, versus 2.38% for Q2 2017 and 2.04% for Q1 2017.